Research and Policy Repository

  • Author: Benjamin Li
Clear all

Retrospective analysis of racial differences in treatment patterns and prostate-specific antigen responses among patients with prostate cancer treated with Relugolix in the Veterans Health Administration

Abstract: Introduction: Relugolix is the only oral androgen deprivation therapy (ADT) approved for advanced prostate cancer (PC). Real-world evidence on treatment patterns and …

Physical Health Peer reviewed